Who are Insilico Medicine's investors?

Insilico Medicine's investors include B Capital Group, B4 Capital, BOLD Longevity, F-Prime Capital Partners, Gestio Capital, LAV, Lilly Asia Ventures, LongeVC and 4 more.

Insilico Medicine

12 known investors

insilico.com ↗

Insilico Medicine applies computational and AI-based modeling to drug design and problems such as protein folding for pharmaceutical research and development. The company operates in the biotechnology and drug discovery sector.

AI & Machine LearningBiotechHealthtechin /in-silico-medicine-inc @InSilicoMeds

Investors · 12

B Capital GroupManhattan Beach · $10M – $50M

B4 Capital$10M – $50M

BOLD LongevityBoston

F-Prime Capital PartnersCambridge · $3M – $10M

Gestio CapitalLondon

LAVHong Kong · $5M – $15M

Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred

LongeVCWashington D.C.

OrbiMedNew York · $1M – $75M

Prosperity7 VenturesDhahran

Qiming Venture PartnersBeijing · $5M – $134M

Warburg PincusNew York

In the news

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths | The Manila Timesmanilatimes.net · Aug 2026

Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science - BioSpacebiospace.com · Jul 2026

Frequently asked questions

What does Insilico Medicine do?: Insilico Medicine applies computational and AI-based modeling to drug design and problems such as protein folding for pharmaceutical research and development. The company operates in the biotechnology and drug discovery sector.
Who are Insilico Medicine's investors?: Insilico Medicine's investors include B Capital Group, B4 Capital, BOLD Longevity, F-Prime Capital Partners, Gestio Capital, LAV, Lilly Asia Ventures, LongeVC and 4 more.